Exhibit 99.1
![](https://capedge.com/proxy/8-K/0001564590-16-020456/ggdhho5q5k5b000001.jpg)
| |
|
|
300 Throckmorton Street |
Fort Worth, TX 76102 |
KMG Reports Third Quarter 2016 Financial Results
FORT WORTH, Texas—(BUSINESS WIRE)—June 9, 2016—KMG (NYSE: KMG), a global provider of specialty chemicals, today announced financial results for the fiscal 2016 third quarter ended April 30, 2016.
2016 Third Quarter Financial Highlights
| · | GAAP diluted earnings per share was $0.53 vs. $0.18 per share in the third quarter of fiscal 2015. |
| · | Adjusted EBITDA1 increased to $11.2 million compared to $9.1 million in last year’s third quarter. |
| · | Adjusted diluted earnings per share2 was $0.41 vs. $0.35 per share reported in the third quarter of last year. |
| · | Long-term debt balance at quarter end was $41.8 million, down from $47 million in the second quarter of fiscal 2016. During the quarter, the company used cash generated from operations to reduce debt by $8 million, and drew $2.8 million on its revolving credit facility to acquire Nagase FineChem. |
Chris Fraser, KMG chairman and chief executive officer, said, “We are pleased with our third quarter results, which included 23% growth in adjusted EBITDA and 17% growth in adjusted diluted earnings per share compared to the prior year period. In addition, we generated $15.3 million in cash from operations in the third quarter, increasing our year-to-date cash flow from operations to $29.4 million − more than triple the level from the same period last year. Our strong financial performance reflects our continued focus on execution and driving operational efficiencies.”
Mr. Fraser continued, “Operating income and margins in our electronic chemicals segment improved 23% year-over-year, benefiting from lower distribution costs and continuing manufacturing efficiency. In April, we advanced our growth strategy in the Electronic Chemicals segment with the acquisition of Nagase FineChem (NFC), a Singapore-based manufacturer of electronic chemicals. This acquisition, coupled with our planned capital investment in Singapore, significantly expands our growth opportunity in Asia. With our enhanced capability in this important region, we can better serve our global customers and elevate our presence in the world’s leading region for semiconductor production.
“Our other chemicals segment reported a 25% improvement in operating income compared to the prior year period, aided by favorable raw materials costs and the contribution from the industrial lubricants business. We continue to identify and evaluate opportunities that would complement our industrial lubricants business and provide new paths for growth.”
1 | Non-U.S. GAAP measure. See Tables 1 and 1A for reconciliation. |
2 | Non-U.S. GAAP measure. See Table 2 for reconciliation. |
Phone: 817.761.6100 ● Fax: 817.761.6001
www.kmgchemicals.com ● NYSE: KMG
![](https://capedge.com/proxy/8-K/0001564590-16-020456/ggdhho5q5k5b000002.jpg)
Consolidated results
Third quarter Dollars in thousands, except EPS | | Fiscal 2016 | | | Fiscal 2015 | |
| | Adjusted | | | As Reported | | | Adjusted | | | As Reported | |
| | (non-GAAP)3 | | | (GAAP) | | | (non-GAAP)4 | | | (GAAP) | |
Net sales | | $ | 75,168 | | | $ | 75,168 | | | $ | 73,964 | | | $ | 73,964 | |
Operating income | | | 8,032 | | | | 7,029 | | | | 6,299 | | | | 4,761 | |
Operating margin | | | 10.7 | % | | | 9.4 | % | | | 8.5 | % | | | 6.4 | % |
Net income | | | 4,944 | | | | 6,362 | | | | 4,099 | | | | 2,135 | |
Diluted earnings per share | | $ | 0.41 | | | $ | 0.53 | | | $ | 0.35 | | | $ | 0.18 | |
Business segment results
Electronic Chemicals | | | | | | | | |
Third quarter | | Fiscal 2016 | | | Fiscal 2015 | |
Dollars in thousands | | As Reported | | | As Reported | |
| | (GAAP) | | | (GAAP) | |
Net sales | | $ | 66,637 | | | $ | 66,388 | |
Operating income | | | 8,183 | | | | 6,644 | |
Operating margin | | | 12.3 | % | | | 10.0 | % |
For the third fiscal quarter, the Electronic Chemicals segment reported:
| · | Sales of $66.6 million vs. $66.4 million in the same period a year ago. Foreign currency translation reduced sales by $400,000 as compared to the prior year period. Sales increased in North America, which more than offset the negative foreign currency impact. |
| · | GAAP operating income of $8.2 million vs. $6.6 million in the same period of fiscal 2015. Operating income and margin improved primarily due to operating efficiencies and lower distribution costs. |
| · | EBITDA5 of $10.7 million, compared to $9.4 million last year. |
3 | Non-U.S. GAAP measure. See Tables 2 and 2A for reconciliation. |
4 | Non-U.S. GAAP measure. See Tables 2 and 2A for reconciliation. |
5 | Non-U.S. GAAP measure. See Tables 1 and 1A for reconciliation. |
Phone: 817.761.6100 ● Fax: 817.761.6001
www.kmgchemicals.com ● NYSE: KMG
2
![](https://capedge.com/proxy/8-K/0001564590-16-020456/ggdhho5q5k5b000002.jpg)
Other Chemicals
As of May 1, 2015, the Other Chemicals segment includes the pentachlorophenol (“penta”) business and the industrial lubricants business.
Third quarter | | | | | | | | |
Dollars in thousands | | Fiscal 2016 | | | Fiscal 2015 | |
| | As Reported | | | As Reported | |
| | (GAAP) | | | (GAAP) | |
Net sales | | $ | 8,531 | | | $ | 7,566 | |
Operating income | | | 2,853 | | | | 2,276 | |
Operating margin | | | 33.4 | % | | | 30.1 | % |
For the third fiscal quarter, the Other Chemicals segment reported:
| · | Sales of $8.5 million versus $7.6 million in the same period a year ago. The increase in sales was due to the contribution from the industrial lubricants business, partially offset by lower penta sales. |
| · | Operating income of $2.9 million, or 33.4% of sales, compared to $2.3 million, or 30.1% of sales, last year. The increase in operating income and margin was due to lower raw material costs and the contribution from the industrial lubricants business. |
| · | EBITDA6 of $3.2 million, up from $2.3 million last year. |
Fiscal 2016 Outlook
| · | Sales: Fiscal 2016 consolidated net sales are forecast to be approximately $300 million, unchanged from our prior guidance. This forecast includes a projected negative foreign currency impact of approximately $6 million. In our Electronic Chemicals segment, we expect sales to be up slightly compared to the prior year, excluding the effect of foreign currency translation. In our Other Chemicals segment, we expect sales to decrease compared to the prior year due to the divestiture of the creosote business, partially offset by the contribution from the industrial lubricants business. |
| · | Adjusted EBITDA: Based on our strong third quarter results and our expectation for continued year-over-year EBITDA growth in both our Electronic Chemicals and Other Chemicals segments in the fourth quarter, we forecast adjusted EBITDA will be at the upper end of our prior guidance range of $43-45 million. Our fiscal 2016 adjusted EBITDA forecast includes approximately $5 million in stock-based compensation expense and a negative foreign currency impact of approximately $600,000. |
| · | Depreciation and Amortization: Depreciation and amortization expense is forecast to be approximately $14 million, excluding restructuring- and realignment-related depreciation, and is unchanged from our prior forecast. |
6 | Non-U.S. GAAP measure. See Tables 1 and 1A for reconciliation. |
Phone: 817.761.6100 ● Fax: 817.761.6001
www.kmgchemicals.com ● NYSE: KMG
3
![](https://capedge.com/proxy/8-K/0001564590-16-020456/ggdhho5q5k5b000002.jpg)
| · | Capital Expenditures: Capital expenditures are forecast to be less than $15 million, compared to our prior forecast of approximately $15 million. |
Conference call
Date: Thursday, June 9, 2016
Time: 5:00 p.m. ET
Dial in: 877-789-6981 or 541-797-2420
Participant passcode: 15841847
The conference call will be webcast live via the “Investors” section of the Company’s website at http://kmgchemicals.com.
If you are unable to listen live, the conference call will be archived on the KMG website. A telephone replay of the call will also be available for one week, starting at 8:00 p.m. ET on June 9, 2016. To access the call, dial 855-859-2056 (domestic) or 404-537-3406 (international) using participant passcode 15841847.
About KMG
KMG Chemicals, Inc., through its subsidiaries, produces and distributes specialty chemicals to select markets. The Company grows by acquiring and optimizing stable chemical product lines and businesses with established production processes. For more information, visit the Company's website at http://kmgchemicals.com.
The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements as to the future performance of the company. Although the company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, product development acceptance, the impact of competitive services and pricing and general economic risks and uncertainties.
Phone: 817.761.6100 ● Fax: 817.761.6001
www.kmgchemicals.com ● NYSE: KMG
4
![](https://capedge.com/proxy/8-K/0001564590-16-020456/ggdhho5q5k5b000002.jpg)
KMG CHEMICALS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(UNAUDITED)
(In thousands, except per share amounts)
| | Three Months Ended | | | Nine Months Ended | |
| | April 30, | | | April 30, | |
| | 2016 | | | 2015 | | | 2016 | | | 2015 | |
Net sales | | $ | 75,168 | | | $ | 73,964 | | | $ | 222,677 | | | $ | 244,505 | |
Cost of sales | | | 46,010 | | | | 47,149 | | | | 136,026 | | | | 161,544 | |
Gross profit | | | 29,158 | | | | 26,815 | | | | 86,651 | | | | 82,961 | |
| | | | | | | | | | | | | | | | |
Distribution expenses | | | 9,177 | | | | 11,700 | | | | 28,125 | | | | 37,721 | |
Selling, general and administrative expenses | | | 12,575 | | | | 9,257 | | | | 36,512 | | | | 28,164 | |
Restructuring charges | | | 377 | | | | 27 | | | | 1,398 | | | | 900 | |
Realignment charges | | | ― | | | | 1,070 | | | | 130 | | | | 5,429 | |
| | | | | | | | | | | | | | | | |
Operating income | | | 7,029 | | | | 4,761 | | | | 20,486 | | | | 10,747 | |
Other income (expense) | | | | | | | | | | | | | | | | |
Interest expense, net | | | (201 | ) | | | (111 | ) | | | (605 | ) | | | (1,098 | ) |
Gain on purchase of NFC | | | 2,069 | | | | ― | | | | 2,069 | | | | ― | |
Gain (loss) on sale of creosote distribution business, net | | | ― | | | | (234 | ) | | | ― | | | | 5,448 | |
Other non-operating expense | | | ― | | | | (1,250 | ) | | | ― | | | | (1,250 | ) |
Other, net | | | (375 | ) | | | (339 | ) | | | (243 | ) | | | (498 | ) |
Total other income (expense), net | | | 1,493 | | | | (1,934 | ) | | | 1,221 | | | | 2,602 | |
| | | | | | | | | | | | | | | | |
Income before income taxes | | | 8,522 | | | | 2,827 | | | | 21,707 | | | | 13,349 | |
Provision for income taxes | | | (2,160 | ) | | | (692 | ) | | | (6,775 | ) | | | (4,539 | ) |
Net income | | $ | 6,362 | | | $ | 2,135 | | | $ | 14,932 | | | $ | 8,810 | |
Earnings per share: | | | | | | | | | | | | | | | | |
Net income per common share basic | | $ | 0.54 | | | $ | 0.18 | | | $ | 1.27 | | | $ | 0.75 | |
Net income per common share diluted | | $ | 0.53 | | | $ | 0.18 | | | $ | 1.25 | | | $ | 0.75 | |
| | | | | | | | | | | | | | | | |
Weighted average shares outstanding: | | | | | | | | | | | | | | | | |
Basic | | | 11,729 | | | | 11,680 | | | | 11,714 | | | | 11,669 | |
Diluted | | | 11,990 | | | | 11,819 | | | | 11,923 | | | | 11,758 | |
Phone: 817.761.6100 ● Fax: 817.761.6001
www.kmgchemicals.com ● NYSE: KMG
5
![](https://capedge.com/proxy/8-K/0001564590-16-020456/ggdhho5q5k5b000002.jpg)
KMG CHEMICALS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except for share and per share amounts)
| | April 30, | | | July 31, | |
| | 2016 | | | 2015 | |
| | (Unaudited) | | | | | |
Assets | | | | | | | | |
Current assets | | | | | | | | |
Cash and cash equivalents | | $ | 10,546 | | | $ | 7,517 | |
Accounts receivable | | | | | | | | |
Trade, net of allowances of $154 at April 30, 2016 and $144 at July 31, 2015 | | 33,952 | | | 36,887 | |
Other | | | 6,242 | | | | 3,668 | |
Inventories, net | | | 39,345 | | | | 42,082 | |
Current deferred tax assets | | | ― | | | | 2,953 | |
Prepaid expenses and other | | | 3,151 | | | | 3,738 | |
Total current assets | | | 93,236 | | | | 96,845 | |
| | | | | | | | |
Property, plant and equipment, net | | | 85,582 | | | | 80,589 | |
Deferred tax assets | | | 707 | | | | 131 | |
Goodwill | | | 22,403 | | | | 22,408 | |
Intangible assets, net | | | 35,062 | | | | 36,560 | |
Restricted cash | | | 1,000 | | | | 1,000 | |
Other assets, net | | | 4,843 | | | | 4,826 | |
Total assets | | $ | 242,833 | | | $ | 242,359 | |
| | | | | | | | |
Liabilities & stockholders’ equity | | | | | | | | |
Current liabilities | | | | | | | | |
Accounts payable | | $ | 28,789 | | | $ | 35,980 | |
Accrued liabilities | | | 11,571 | | | | 9,602 | |
Employee incentive accrual | | | 4,714 | | | | 4,852 | |
Total current liabilities | | | 45,074 | | | | 50,434 | |
| | | | | | | | |
Long-term debt | | | 41,800 | | | | 53,000 | |
Deferred tax liabilities | | | 10,188 | | | | 13,075 | |
Other long-term liabilities | | | 4,628 | | | | 2,429 | |
Total liabilities | | | 101,690 | | | | 118,938 | |
| | | | | | | | |
Commitments and contingencies | | | | | | | | |
| | | | | | | | |
Stockholders’ equity | | | | | | | | |
Preferred stock, $.01 par value, 10,000,000 shares authorized, none issued | | | ― | | | | ― | |
Common stock, $.01 par value, 40,000,000 shares authorized, 11,735,793 shares issued and outstanding at April 30, 2016 and 11,690,439 shares issued and outstanding at July 31, 2015 | | 117 | | | 117 | |
Additional paid-in capital | | | 35,349 | | | | 31,676 | |
Accumulated other comprehensive loss | | | (9,497 | ) | | | (9,667 | ) |
Retained earnings | | | 115,174 | | | | 101,295 | |
Total stockholders’ equity | | | 141,143 | | | | 123,421 | |
Total liabilities and stockholders’ equity | | $ | 242,833 | | | $ | 242,359 | |
Phone: 817.761.6100 ● Fax: 817.761.6001
www.kmgchemicals.com ● NYSE: KMG
6
![](https://capedge.com/proxy/8-K/0001564590-16-020456/ggdhho5q5k5b000002.jpg)
KMG CHEMICALS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(In thousands)
| | Nine Months Ended | |
| | April 30, | |
| | | 2016 | | | | 2015 | |
Cash flows from operating activities | | | | | | | | |
Net income | | $ | 14,932 | | | $ | 8,810 | |
Adjustments to reconcile net income to net cash provided by operating activities | | | | | | | | |
Depreciation and amortization | | | 10,606 | | | | 9,951 | |
Non-cash restructuring & realignment charges | | | 295 | | | | 5,640 | |
Amortization of loan costs | | | 125 | | | | 111 | |
Stock-based compensation expense | | | 3,659 | | | | 1,970 | |
Allowance for excess and obsolete inventory | | | 173 | | | | 760 | |
Gain on sale of creosote distribution business | | − | | | | (5,448 | ) |
Gain on purchase of NFC | | | (2,069 | ) | | − | |
Deferred income tax expense (benefit) | | | (219) | | | | (4,374 | ) |
Other | | | 28 | | | | (10 | ) |
Changes in operating assets and liabilities | | | | | | | | |
Accounts receivable — trade | | | 5,022 | | | | 95 | |
Accounts receivable — other | | | (2,515 | ) | | | (1,756 | ) |
Inventories | | | 2,798 | | | | 965 | |
Other current and noncurrent assets | | | 541 | | | | (1,386 | ) |
Accounts payable | | | (7,257 | ) | | | (4,897 | ) |
Accrued liabilities and other | | | 3,234 | | | | (2,219 | ) |
Net cash provided by operating activities | | | 29,353 | | | | 8,212 | |
| | | | | | | | |
Cash flows from investing activities | | | | | | | | |
Additions to property, plant and equipment | | | (11,377 | ) | | | (10,751 | ) |
Purchase of NFC, net of cash acquired | | | (2,572 | ) | | − | |
Disposals of property, plant and equipment | | − | | | | 2,561 | |
Proceeds from sale of creosote product distribution business | | − | | | | 14,899 | |
Net cash (used in) provided by investing activities | | | (13,949 | ) | | | 6,709 | |
| | | | | | | | |
Cash flows from financing activities | | | | | | | | |
Net payments under revolving credit agreement | | − | | | | (41,100 | ) |
Principal payments on term loan | | − | | | | (20,000 | ) |
Borrowings under new credit facility | | | 2,800 | | | | 59,100 | |
Payments under new credit facility | | | (14,000 | ) | | | (23,000 | ) |
Tax benefit from stock-based awards | | | 38 | | | | 10 | |
Payment of dividends | | | (1,053 | ) | | | (1,050 | ) |
Net cash used in financing activities | | | (12,215 | ) | | | (26,040 | ) |
| | | | | | | | |
Effect of exchange rate changes on cash | | | (160 | ) | | | (1,293 | ) |
| | | | | | | | |
Net increase (decrease) in cash and cash equivalents | | | 3,029 | | | | (12,412 | ) |
| | | | | | | | |
Cash and cash equivalents at beginning of period | | | 7,517 | | | | 19,252 | |
Cash and cash equivalents at end of period | | $ | 10,546 | | | $ | 6,840 | |
Phone: 817.761.6100 ● Fax: 817.761.6001
www.kmgchemicals.com ● NYSE: KMG
7
![](https://capedge.com/proxy/8-K/0001564590-16-020456/ggdhho5q5k5b000002.jpg)
Reconciliation of GAAP financial measures to non-GAAP financial measures
KMG provides non-GAAP financial information to complement reported GAAP results. KMG believes that analysis of our financial performance would be enhanced by an understanding of the factors underlying that performance and our judgments about the likelihood that particular factors will repeat. We define adjusted EBITDA as earnings from operations before interest, taxes, depreciation, amortization, acquisition and integration expenses, restructuring and realignment charges and other relevant items.
KMG intends to continue to provide certain non-GAAP financial information and the appropriate reconciliation to GAAP in its financial results. As required by SEC rules, the tables below present a reconciliation of our presented non-GAAP measures to the most directly comparable GAAP measures. These non-GAAP measures should be viewed as a supplement to, and not a substitute for, U.S. GAAP measures of performance.
Table 1
RECONCILIATION OF CONSOLIDATED GAAP NET INCOME TO CONSOLIDATED EBITDA
(in thousands)
| | Third Quarter Fiscal 2016 | | | Nine Months Ended April 30, 2016 | |
Consolidated GAAP net income | | $ | 6,362 | | | $ | 14,932 | |
Add back (deduct): | | | | | | | | |
Income taxes | | | 2,160 | | | | 6,775 | |
Gain on purchase of NFC | | | (2,069 | ) | | | (2,069 | ) |
Interest expense | | | 201 | | | | 605 | |
Depreciation & amortization* | | | 3,772 | | | | 10,901 | |
Consolidated EBITDA | | $ | 10,426 | | | $ | 31,144 | |
*Includes depreciation related to restructuring and realignment included in non-cash restructuring and realignment charges on the statement of cash flows. |
| | Third Quarter Fiscal 2015 | | | Nine Months Ended April 30, 2015 | |
Consolidated GAAP net income | | $ | 2,135 | | | $ | 8,810 | |
Add back (deduct): | | | | | | | | |
Income taxes | | | 692 | | | | 4,539 | |
Other non-operating expense | | | 1,250 | | | | 1,250 | |
Loss (gain) on sale of creosote distribution business | | | 234 | | | | (5,448 | ) |
Interest expense | | | 111 | | | | 1,098 | |
Depreciation & amortization* | | | 3,894 | | | | 15,591 | |
Consolidated EBITDA | | $ | 8,316 | | | $ | 25,840 | |
*Includes depreciation related to restructuring and realignment included in non-cash restructuring and realignment charges on the statement of cash flows. |
Phone: 817.761.6100 ● Fax: 817.761.6001
www.kmgchemicals.com ● NYSE: KMG
8
![](https://capedge.com/proxy/8-K/0001564590-16-020456/ggdhho5q5k5b000002.jpg)
Table 1A
RECONCILIATION OF OPERATING INCOME TO EBITDA AND ADJUSTED EBITDA
(in thousands)
Note that we do not allocate certain financial statement line items below operating income to our segments; as such, the reconciliations below only reflect the reconciliation of our operating income by segment to our non-GAAP measures.
Third Quarter Fiscal 2016 | | Electronic | | | Other | | | | | | | | | |
| | Chemicals | | | Chemicals | | | Corporate | | | Total | |
Operating Income (Loss) | | $ | 8,183 | | | $ | 2,853 | | | $ | (4,007 | ) | | $ | 7,029 | |
Other income (expense) | | | (401 | ) | | | 17 | | | | 9 | | | | (375 | ) |
Depreciation and amortization | | | 2,896 | | | | 285 | | | | 591 | | | | 3,772 | |
EBITDA | | | 10,678 | | | | 3,155 | | | | (3,407 | ) | | | 10,426 | |
Acquisition & integration expenses | | | — | | | | — | | | | 233 | | | | 233 | |
Restructuring charges* | | | — | | | | — | | | | 187 | | | | 187 | |
Corporate relocation expense | | | — | | | | — | | | | 393 | | | | 393 | |
Adjusted EBITDA | | | 10,678 | | | | 3,155 | | | | (2,594 | ) | | | 11,239 | |
Corporate allocation | | | 2,818 | | | | 992 | | | | (3,810 | ) | | | — | |
Adjusted EBITDA excl. corporate allocation | | $ | 13,496 | | | $ | 4,147 | | | $ | (6,404 | ) | | $ | 11,239 | |
* Excludes depreciation |
Nine Months Ended April 30, 2016 | | Electronic | | | Other | | | | | | | | | |
| | Chemicals | | | Chemicals | | | Corporate | | | Total | |
Operating Income (Loss) | | $ | 23,927 | | | $ | 9,421 | | | $ | (12,862 | ) | | $ | 20,486 | |
Other income (expense) | | | (75 | ) | | | (75 | ) | | | (93 | ) | | | (243 | ) |
Depreciation and amortization | | | 8,660 | | | | 868 | | | | 1,373 | | | | 10,901 | |
EBITDA | | | 32,512 | | | | 10,214 | | | | (11,582 | ) | | | 31,144 | |
Acquisition & integration expenses | | | — | | | | — | | | | 233 | | | | 233 | |
Restructuring & realignment charges* | | | — | | | | — | | | | 1,233 | | | | 1,233 | |
Corporate relocation expense | | | — | | | | — | | | | 1,122 | | | | 1,122 | |
Adjusted EBITDA | | | 32,512 | | | | 10,214 | | | | (8,994 | ) | | | 33,732 | |
Corporate allocation | | | 7,779 | | | | 2,573 | | | | (10,352 | ) | | | — | |
Adjusted EBITDA excl. corporate allocation | | $ | 40,291 | | | $ | 12,787 | | | $ | (19,346 | ) | | $ | 33,732 | |
* Excludes depreciation |
Phone: 817.761.6100 ● Fax: 817.761.6001
www.kmgchemicals.com ● NYSE: KMG
9
![](https://capedge.com/proxy/8-K/0001564590-16-020456/ggdhho5q5k5b000002.jpg)
(Table 1A continued)
Third Quarter Fiscal 2015 | | Electronic | | | Wood Treating | | | | | | | | | |
| | Chemicals | | | Chemicals | | | Corporate | | | Total | |
Operating Income (Loss) | | $ | 6,644 | | | $ | 2,276 | | | $ | (4,159 | ) | | $ | 4,761 | |
Other income (expense) | | | (193 | ) | | | (37 | ) | | | (109 | ) | | | (339 | ) |
Depreciation and amortization | | | 2,983 | | | | 93 | | | | 818 | | | | 3,894 | |
EBITDA | | | 9,434 | | | | 2,332 | | | | (3,450 | ) | | | 8,316 | |
| | | | | | | | | | | | | | | | |
Acquisition & integration expenses | | | — | | | | — | | | | 441 | | | | 441 | |
Restructuring & realignment charges* | | | — | | | | — | | | | 388 | | | | 388 | |
Adjusted EBITDA | | | 9,434 | | | | 2,332 | | | | (2,621 | ) | | | 9,145 | |
Corporate allocation | | | 1,802 | | | | 597 | | | | (2,399 | ) | | | — | |
Adjusted EBITDA excl. corporate allocation | | $ | 11,236 | | | $ | 2,929 | | | $ | (5,020 | ) | | $ | 9,145 | |
* Excludes depreciation |
Nine Months Ended April 30, 2015 | | Electronic | | | Wood Treating | | | | | | | | | |
| | Chemicals | | | Chemicals | | | Corporate | | | Total | |
Operating Income (Loss) | | $ | 16,335 | | | $ | 6,456 | | | $ | (12,044 | ) | | $ | 10,747 | |
Other income (expense) | | | (76 | ) | | | (90 | ) | | | (332 | ) | | | (498 | ) |
Depreciation and amortization | | | 9,311 | | | | 286 | | | | 5,994 | | | | 15,591 | |
EBITDA | | | 25,570 | | | | 6,652 | | | | (6,382 | ) | | | 25,840 | |
| | | | | | | | | | | | | | | | |
Acquisition & integration expenses | | | — | | | | — | | | | 441 | | | | 441 | |
Restructuring & realignment charges* | | | — | | | | — | | | | 689 | | | | 689 | |
Adjusted EBITDA | | | 25,570 | | | | 6,652 | | | | (5,252 | ) | | | 26,970 | |
Corporate allocation | | | 7,192 | | | | 2,704 | | | | (9,896 | ) | | | — | |
Adjusted EBITDA excl. corporate allocation | | $ | 32,762 | | | $ | 9,356 | | | $ | (15,148 | ) | | $ | 26,970 | |
* Excludes depreciation |
Table 2
RECONCILIATION OF NET INCOME TO ADJUSTED NET INCOME AND ADJUSTED DILUTED EARNINGS PER SHARE
(in thousands)
| | Three Months Ended April 30, | | | Nine Months Ended April 30, | |
| | 2016 | | | 2015 | | | 2016 | | | 2015 | |
Net income | | $ | 6,362 | | | $ | 2,135 | | | $ | 14,932 | | | $ | 8,810 | |
Items impacting pre-tax income: | | | | | | | | | | | | | | | | |
Restructuring & realignment charges | | | 377 | | | | 1,097 | | | | 1,528 | | | | 6,329 | |
Acquisition & integration expenses | | | 233 | | | | 441 | | | | 233 | | | | 441 | |
Corporate relocation expense | | | 393 | | | − | | | | 1,122 | | | − | |
Gain on purchase of NFC | | | (2,069 | ) | | − | | | | (2,069 | ) | | − | |
Loss (gain) on sale of creosote business | | − | | | | 234 | | | − | | | | (5,448 | ) |
Environmental site cleanup reserve | | − | | | | 1,250 | | | − | | | | 1,250 | |
Income taxes* | | | (352 | ) | | | (1,058 | ) | | | (1,010 | ) | | | (900 | ) |
Adjusted net income | | $ | 4,944 | | | $ | 4,099 | | | $ | 14,736 | | | $ | 10,482 | |
Adjusted diluted earnings per share | | $ | 0.41 | | | $ | 0.35 | | | $ | 1.24 | | | $ | 0.89 | |
Weighted average diluted shares outstanding | | | 11,990 | | | | 11,819 | | | | 11,923 | | | | 11,758 | |
| | | | | | | | | | | | | | | | |
*Represents the aggregate tax-effect of the items impacting pre-tax income, except for the gain on the purchase of NFC, which is not a recognized gain for tax purposes. |
Phone: 817.761.6100 ● Fax: 817.761.6001
www.kmgchemicals.com ● NYSE: KMG
10
![](https://capedge.com/proxy/8-K/0001564590-16-020456/ggdhho5q5k5b000002.jpg)
Table 2A
RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES
Third Quarter Fiscal 2016 | | KMG Chemicals, Inc. | |
Dollars in thousands, except EPS | | | | | | | | | | | | | | | | |
| | Operating | | | Net | | | Diluted Earnings | |
| | Income | | | Margin | | | Income | | | Per Share | |
GAAP measure | | $ | 7,029 | | | | 9.4 | % | | $ | 6,362 | | | $ | 0.53 | |
Acquisition & integration expenses | | | 233 | | | | 0.3 | % | | | 151 | | | | 0.01 | |
Restructuring charges | | | 377 | | | | 0.5 | % | | | 245 | | | | 0.02 | |
Gain on purchase of NFC | | | — | | | | 0.0 | % | | | (2,069 | ) | | | (0.17 | ) |
Corporate relocation expense | | | 393 | | | | 0.5 | % | | | 255 | | | | 0.02 | |
Non-GAAP measure | | $ | 8,032 | | | | 10.7 | % | | $ | 4,944 | | | $ | 0.41 | |
Nine Months Ended April 30, 2016 | | KMG Chemicals, Inc. | |
Dollars in thousands, except EPS | | | | | | | | | | | | | | | | |
| | Operating | | | Net | | | Diluted Earnings | |
| | Income | | | Margin | | | Income | | | Per Share | |
GAAP measure | | $ | 20,486 | | | | 9.2 | % | | $ | 14,932 | | | $ | 1.25 | |
Acquisition & integration expenses | | | 233 | | | | 0.1 | % | | | 151 | | | | 0.01 | |
Restructuring & realignment charges | | | 1,528 | | | | 0.7 | % | | | 993 | | | | 0.09 | |
Gain on purchase of NFC | | | — | | | | 0.0 | % | | | (2,069 | ) | | | (0.17 | ) |
Corporate relocation expense | | | 1,122 | | | | 0.5 | % | | | 729 | | | | 0.06 | |
Non-GAAP measure | | $ | 23,369 | | | | 10.5 | % | | $ | 14,736 | | | $ | 1.24 | |
Third Quarter Fiscal 2015 | | KMG Chemicals, Inc. | |
Dollars in thousands, except EPS | | | | | | | | | | | | | | | | |
| | Operating | | | Net | | | Diluted Earnings | |
| | Income | | | Margin | | | Income | | | Per Share | |
GAAP measure | | $ | 4,761 | | | | 6.4 | % | | $ | 2,135 | | | $ | 0.18 | |
Restructuring & realignment charges | | | 1,097 | | | | 1.5 | % | | | 713 | | | | 0.06 | |
Acquisition & integration expenses | | | 441 | | | | 0.6 | % | | | 287 | | | | 0.03 | |
Loss on sale of creosote business | | | — | | | | 0.0 | % | | | 152 | | | | 0.01 | |
Environmental site cleanup reserve | | | — | | | | 0.0 | % | | | 812 | | | | 0.07 | |
Non-GAAP measure | | $ | 6,299 | | | | 8.5 | % | | $ | 4,099 | | | $ | 0.35 | |
Nine Months Ended April 30, 2015 | | KMG Chemicals, Inc. | |
Dollars in thousands, except EPS | | | | | | | | | | | | | | | | |
| | Operating | | | Net | | | Diluted Earnings | |
| | Income | | | Margin | | | Income | | | Per Share | |
GAAP measure | | $ | 10,747 | | | | 4.4 | % | | $ | 8,810 | | | $ | 0.75 | |
Restructuring & realignment charges | | | 6,329 | | | | 2.6 | % | | | 4,114 | | | | 0.35 | |
Acquisition & integration expenses | | | 441 | | | | 0.2 | % | | | 287 | | | | 0.02 | |
Gain on sale of creosote business | | | — | | | | 0.0 | % | | | (3,541 | ) | | | (0.30 | ) |
Environmental site cleanup reserve | | | — | | | | 0.0 | % | | | 812 | | | | 0.07 | |
Non-GAAP measure | | $ | 17,517 | | | | 7.2 | % | | $ | 10,482 | | | $ | 0.89 | |
KMG Investor Relations
Eric Glover, 817-761-6006
eglover@kmgchemicals.com
Phone: 817.761.6100 ● Fax: 817.761.6001
www.kmgchemicals.com ● NYSE: KMG
11